Results 91 to 100 of about 2,525 (153)

Insights into <i>Klebsiella pneumoniae</i> carbapenem resistance-a two-year retrospective study from a Romanian tertiary care hospital. [PDF]

Front Microbiol
Tălăpan D, Dan MO, Cireşă A, Rafila A.   +3 more
europepmc   +1 more source

Classification and applicability of new beta-lactamase inhibitors. [PDF]

Rev Esp Quimioter
Cercenado E, Candel FJ.
europepmc   +1 more source

Emergence of co-resistance to imipenem/relebactam and ceftazidime/avibactam in clinical <i>Klebsiella pneumoniae</i> ST11 clone due to KPC-2 N132S and CTX-M-65 S130G/P167S substitutions. [PDF]

Antimicrob Agents Chemother
Fu Y, Zhang Y, Zhao J, Xie J, Kong H, Yang T, Chen W, Xu M.   +7 more
europepmc   +1 more source

Can we escape from top-priority ESKAPE pathogens? [PDF]

Emerg Microbes Infect
Zeng L, Feng Y, Wang M.
europepmc   +1 more source

Imipenem/Relebactam Plus Aztreonam: First Reported Use in MDR <i>Klebsiella pneumoniae</i> Sternal Infection Complicated by Bacteremia. [PDF]

Antibiotics (Basel)
Pipitò L, Rubino R, Immordino R, Bono E, Fasciana T, Bonura C, Giammanco GM, Argano V, Cascio A.   +8 more
europepmc   +1 more source

Guideline for antimicrobial treatment of multidrug-resistant Gram-negative infections: practice recommendations of the Brazilian Society of Infectious Diseases. [PDF]

Braz J Infect Dis
Zavascki AP, Chebabo A, Cunha CA, Silva AR, Cuba GT, Santos DWCL, Gales AC.   +6 more
europepmc   +1 more source

Introduction to XIV updating course of antimicrobials and infectious diseases. [PDF]

Rev Esp Quimioter
Candel FJ, Matesanz M.
europepmc   +1 more source

Rapid prediction of carbapenemases in by imipenem/relebactam and MALDI-TOF MS

Pseudomonas aeruginosa is a major nosocomial pathogen commonly involved in multidrug-resistant (MDR) infections that are very difficult to treat. Imipenem/relebactam is a new carbapenem/β-lactamase inhibitor combination with robust activity against P. aeruginosa.
Candela, Ana, Fernández-Billón, María, Aja-Macaya, Pablo, González-Pinto, Lucía, Fraile Ribot, Pablo Arturo, Viedma, Esther, Alonso-García, Isaac, Blanco-Martín, Tania, Estévez-Alfaya, Roberto, Fernández-González, Ana, Beceiro, Alejandro, López-Causapé, Carla, Oviaño, Marina, Bou, Germán, Oliver, Antonio, Arca-Suárez, Jorge   +15 more
openaire   +1 more source

Efficacy and safety of imipenem/cilastatin/relebactam (IMI/CS/REL): a meta-analysis of randomized controlled clinical trials. [PDF]

BMC Infect Dis
Lei W, Duan Y, Xin M, Tian M, Xu J.
europepmc   +1 more source

Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023). [PDF]

Antibiotics (Basel)
Sader HS, Winkler ML, Papp-Wallace KM, Mendes RE, Castanheira M.   +4 more
europepmc   +1 more source